MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
0.2500
-0.0365
-12.74%
Pre Market: 0.2503 +0.0003 +0.12% 04:26 12/18 EST
OPEN
0.2871
PREV CLOSE
0.2865
HIGH
0.3250
LOW
0.2500
VOLUME
500
TURNOVER
0
52 WEEK HIGH
2.750
52 WEEK LOW
0.2500
MARKET CAP
7.43M
P/E (TTM)
-0.1272
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GOVX last week (1208-1212)?
Weekly Report · 3d ago
GeoVax Labs Files Prospectus For Best-Efforts Offering Of 18,292,683 Units And Pre-Funded Units With Warrants
Benzinga · 5d ago
*GeoVax Labs Offering 18.3M Units, Each Consisting of One Share and Two Warrants; Certain Investors May Choose Pre-Funded Units in Lieu of Common Units
Dow Jones · 5d ago
GEOVAX LABS: FILES FOR PROSPECTUS RELATES TO PUBLIC OFFERING OF 18.3 MLN UNITS - SEC FILING
Reuters · 5d ago
GeoVax Labs files to sell 18.29M units
TipRanks · 5d ago
Weekly Report: what happened at GOVX last week (1201-1205)?
Weekly Report · 12/08 09:40
Weekly Report: what happened at GOVX last week (1124-1128)?
Weekly Report · 12/01 09:38
GeoVax Labs Approves Share Issuance and Reverse Split
TipRanks · 11/26 21:38
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.